Effect of PCSK9 Inhibitors on Clinical Outcomes in Patients With Hypercholesterolemia: A Meta‐Analysis of 35 Randomized Controlled Trials

gan Karatasakis, Aris, Danek, Barbara A, Karacsonyi, Judit, Rangan, Bavana V, Roesle, Michele K, Knickelbine, Thomas, Miedema, Michael D, Khalili, Houman, Ahmad, Zahid, Abdullah, Shuaib, Banerjee, Subhash, Brilakis, Emmanouil S.
Cyhoeddwyd yn J Am Heart Assoc (2017)

Prevalence and Management of Coronary Chronic Total Occlusions in a Tertiary Veterans Affairs Hospital

gan Jeroudi, Omar M., Alomar, Mohammed E., Michael, Tesfaldet T., Sabbagh, Abdallah El, Patel, Vishal G., Mogabgab, Owen, Fuh, Eric, Sherbet, Daniel, Lo, Nathan, Roesle, Michele, Rangan, Bavana V., Abdullah, Shuaib M., Hastings, Jeffrey L., Grodin, Jerrold, Banerjee, Subhash, Brilakis, Emmanouil S.
Cyhoeddwyd 2013

Saphenous Vein Graft Near-Infrared Spectroscopy Imaging Insights from the Lipid cORe Plaque Association with CLinical Events Near-InfraRed Spectroscopy (ORACLE-NIRS) Registry

gan Danek, Barbara A., Karatasakis, Aris, Alame, Aya J., Nguyen-Trong, Phuong-Khanh J., Karacsonyi, Judit, Rangan, Bavana, Roesle, Michele, Atwell, Amy, Resendes, Erica, Martinez-Parachini, Jose Roberto, Iwnetu, Rahel, Kalsaria, Pratik, Siddiqui, Furqan, Muller, James E., Banerjee, Subhash, Brilakis, Emmanouil
Cyhoeddwyd yn Catheter Cardiovasc Interv (2016)

Outcomes with Use of the Retrograde Approach for Coronary Chronic Total Occlusion Interventions in a Contemporary Multicenter US Registry

gan Karmpaliotis, Dimitri, Karatasakis, Aris, Alaswad, Khaldoon, Jaffer, Farouc A., Yeh, Robert W., Wyman, R. Michael, Lombardi, William L., Grantham, J. Aaron, Kandzari, David E., Lembo, Nicholas J., Doing, Anthony, Patel, Mitul, Bahadorani, John N., Moses, Jeffrey W., Kirtane, Ajay J., Parikh, Manish, Ali, Ziad A., Kalra, Sanjog, Nguyen-Trong, Phuong-Khanh J, Danek, Barbara A., Karacsonyi, Judit, Rangan, Bavana V., Roesle, Michele K., Thompson, Craig A., Banerjee, Subhash, Brilakis, Emmanouil S.
Cyhoeddwyd yn Circ Cardiovasc Interv (2016)